Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

RETRACTED: Structure–Activity Relationship of Synthetic Linear KTS-Peptides Containing Meta-Aminobenzoic Acid as Antagonists of α1β1 Integrin with Anti-Angiogenic and Melanoma Anti-Tumor Activities

Title: RETRACTED: Structure–Activity Relationship of Synthetic Linear KTS-Peptides Containing Meta-Aminobenzoic Acid as Antagonists of α1β1 Integrin with Anti-Angiogenic and Melanoma Anti-Tumor Activities
Authors: Naamneh, Majdi Saleem; Momić, Tatjana; Klazas, Michal; Grosche, Julius; Eble, Johannes A.; Marcinkiewicz, Cezary; Khazanov, Netaly; Senderowitz, Hanoch; Hoffman, Amnon; Gilon, Chaim; Katzhendler, Jehoshua; Lazarovici, Philip
Source: Pharmaceuticals
Publication Year: 2024
Collection: VinaR Repository (Vinča Institute of Nuclear Sciences / University of Belgrade)
Subject Terms: MABA; KTS; peptide synthesis; modeling; conformation; stability; integrin α1; cell adhesion; angiogenesis; melanoma tumor
Description: The journal retracts the article titled “Structure–Activity Relationship of Synthetic Linear KTS-Peptides Containing Meta-Aminobenzoic Acid as Antagonists of α1β1 Integrin with Anti-Angiogenic and Melanoma Anti-Tumor Activities” [1], cited above. Following publication, concerns were brought to the attention of the Editorial Office regarding a range of image irregularities contained within this article [1]. Adhering to our standard procedure, an investigation was conducted by the Editorial Office and Editorial Board that identified indications of inappropriate editing and partial duplication between figures presented in this article [1] and earlier publications [2,3], produced by a different research group. While the authors collaborated within this process, raw material meeting the journal’s requirements for original images could not be provided for Editorial Board evaluation (https://www.mdpi.com/journal/molecules/instructions#oriimages, accessed on 20 August 2025). Consequently, the Editorial Board has lost confidence in the reliability of the findings and has decided to retract this publication, as per MDPI’s retraction policy (https://www.mdpi.com/ethics#_bookmark30, accessed on 20 August 2025). This retraction was approved by the Editor-in-Chief of the Pharmaceuticals journal. Johannes A. Eble agrees to this retraction. The remaining authors disagree with this retraction. ; RETRACTION - This article has been retracted. Please see the retraction notice for more detail: [https://doi.org/10.3390/ph18091400]
Document Type: article in journal/newspaper
Language: unknown
Relation: Hebrew University-YISSUM Internal funds [PL-2014]; Deutsche Forschungsgemeinschaft [Grant no. 446302350; SFB1009-A09]; https://vinar.vin.bg.ac.rs/handle/123456789/15666; https://vinar.vin.bg.ac.rs/handle/123456789/13297
DOI: 10.3390/ph17050549
Availability: https://vinar.vin.bg.ac.rs/handle/123456789/13297; https://doi.org/10.3390/ph17050549; http://vinar.vin.bg.ac.rs/bitstream/id/44149/RETRACTED_pharmaceuticals-17-00549-v2.pdf.pdf
Rights: openAccess ; https://creativecommons.org/licenses/by/4.0/ ; BY
Accession Number: edsbas.520B5FB2
Database: BASE